Losartan treating podocyte injury induced by Ang II via downregulation of TRPC6 in podocytes

被引：5
|
作者：
Chi-Xianggeng [1 ]
Hu-Bo [2 ]
Yu, S. Y. [3 ]
Yin-Lianghong [2 ]
Meng-Yu [2 ]
Wang-Boxun [2 ]
Yang-Jinsheng [2 ]
Lin-Jiahui [2 ]
Huang-Dexu [2 ]
Chen-lanlan [4 ]
机构：
[1] Southern Med Univ, Affiliated Xiaolan Hosp, Dept Nephrol, Zhong Shan, Peoples R China
[2] JiNan Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China
[4] GongAn Hosp Tradit Chinese Med, Wuhan, HuBei, Peoples R China
来源：
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 2015年 / 16卷 / 04期
关键词：
Losartan; TRPC6; proteinuria; podocyte; signal pathway; CHANNELS; INHIBITION; FILTRATION; EXPRESSION;
D O I：
10.1177/1470320315573682
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Objective: In this study, we investigated the molecule mechanisms of podocyte injury and proteinuria and the protective effects of losartan. Methods: This study set up three groups: a control group; an Ang II group (Ang II 10(-6) mol/l, Sigma); and a losartan group (losartan 10(-6) mol/l, Sigma). We used RT-PCR assay to detect TRPC6 mRNA expression, and Western blot to detect TRPC6 protein expression. Results: TRPC6 overexpression was the basic change of podocyte injury and proteinuria occurrence. Losartan can treat podocyte injury and proteinuria induced by Ang II via downregulation of TRPC6 in podocytes. Conclusion: These findings maybe provide an ideal drug target for the diagnosis and treatment of acquired glomerular diseases.
引用
收藏
页码：1118 / 1124
页数：7
相关论文
共 50 条
  • [41] Adriamycin-induced podocyte injury via the Sema3A/TRPC5/Rac1 pathway
    Liu, Yan
    Ge, Ri-Li
    Shan, Zhen-Zhen
    Wang, Yan-Jun
    Yang, Yan-Yan
    Sun, Xue
    Luo, Peng-Li
    FRONTIERS IN MEDICINE, 2024, 11
  • [42] TRPC6 mediates high glucose-induced mitochondrial fission through activation of CDK5 in cultured human podocytes
    Yu, Haomiao
    Chen, Yili
    Ma, Huimin
    Wang, Zihan
    Zhang, Rui
    Jiao, Jundong
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [43] The mTORC2/Akt/ NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis
    Zhang, Hai-Tao
    Wang, Wei-Wei
    Ren, Li-Hong
    Zhao, Xia-Xia
    Wang, Zhi-Hui
    Zhuang, De-Li
    Bai, Yun-Nuo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 40 (05) : 1079 - 1093
  • [44] TRPC6 regulates necroptosis in myocardial ischemia/reperfusion injury via Ca2+/CaMKII signaling pathway
    Li, Junhao
    Zhang, Jiaji
    Zhong, Yunlong
    Xie, Dongge
    Han, Han
    Zhang, Zhongqing
    Liu, Yong
    Li, Shoutian
    CELLULAR SIGNALLING, 2024, 122
  • [45] TGF-β1 Induces Podocyte Injury Through Smad3-ERK-NF-κB Pathway and Fyn-dependent TRPC6 phosphorylation
    Yu, Lixia
    Lin, Qiuxia
    Liao, Hua
    Feng, Jianhua
    Dong, Xiaohong
    Ye, Jianming
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 26 (06) : 869 - 878
  • [46] High glucose-induced apoptosis in cultured podocytes involves TRPC6-dependent calcium entry via the RhoA/ROCK pathway
    Yang, He
    Zhao, Bo
    Liao, Chang
    Zhang, Rui
    Meng, Kexin
    Xu, Jia
    Jiao, Jundong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (02) : 394 - 400
  • [47] Over-Expression of TRPC6 via CRISPR Based Synergistic Activation Mediator in BMSCs Ameliorates Brain Injury in a Rat Model of Cerebral Ischemia/Reperfusion
    Li, Wenbin
    Yang, Fan
    Gao, Jinxing
    Tang, Yushi
    Wang, Jing
    Pan, Yujun
    NEUROSCIENCE, 2019, 415 : 147 - 160
  • [48] Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes
    Yang, Qian
    Hu, Jijia
    Yang, Yingjie
    Chen, Zhaowei
    Feng, Jun
    Zhu, Zijing
    Wang, Huiming
    Yang, Dingping
    Liang, Wei
    Ding, Guohua
    THERANOSTICS, 2020, 10 (16): : 7465 - 7479
  • [49] Necrostatin-1 Attenuates Renal Ischemia and Reperfusion Injury via Meditation of HIF-1α/mir-26a/TRPC6/PARP1 Signaling
    Shen, Bingbing
    Mei, Mei
    Pu, Youmin
    Zhang, Huhai
    Liu, Hong
    Tang, Maozhi
    Pan, Qianguang
    He, Yue
    Wu, Xiongfei
    Zhao, Hongwen
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 701 - 713
  • [50] Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6
    Li, Huili
    Wang, Yuanyuan
    Zhou, Zhangqing
    Tian, Fang
    Yang, Huanhuan
    Yan, Juzhen
    RENAL FAILURE, 2019, 41 (01) : 899 - 906
12345